ArticleJournal of medical virology2020

The anti-HIV drug nelfinavir mesylate (Viracept) is a potent inhibitor of cell fusion caused by the SARSCoV-2 spike (S) glycoprotein warranting further evaluation as an antiviral against COVID-19 infections.

Farhana Musarrat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.